These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7446417)

  • 1. Modification of ventricular tachycardia by procainamide in patients with coronary artery disease.
    Engel TR; Meister SG; Luck JC
    Am J Cardiol; 1980 Dec; 46(6):1033-8. PubMed ID: 7446417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procainamide in the induction and perpetuation of ventricular tachycardia in man.
    Kang PS; Gomes JA; El-Sherif N
    Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
    Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A
    Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
    J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
    Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
    Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms.
    Callans DJ; Marchlinski FE
    J Am Coll Cardiol; 1992 Jan; 19(1):111-7. PubMed ID: 1729321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of procainamide on induced ventricular tachycardia.
    Engel TR; del Gonzalez A; Meister SG; Franki WS
    Clin Pharmacol Ther; 1978 Sep; 24(3):274-82. PubMed ID: 688720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of sotalol and procainamide in symptomatic ventricular tachycardia.
    Jordaens LJ; Colardyn F; Clement DL
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):155-61. PubMed ID: 2487531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
    Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
    Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
    Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
    Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paired comparisons of efficacy of intravenous and oral procainamide in patients with inducible sustained ventricular tachyarrhythmias.
    Interian A; Zaman L; Velez-Robinson E; Kozlovskis P; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1991 Jun; 17(7):1581-6. PubMed ID: 2033190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil in ventricular tachycardia.
    Hasin Y; Kriwisky M; Gotsman MS
    Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
    Morady F; DiCarlo LA; de Buitleir M; Krol RB; Baerman JM; Kou WH
    Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of ventricular tachycardia initiation by procainamide during programmed ventricular stimulation in patients with heart failure.
    Stevenson WG; Weiss J; Stevenson LW; Tillisch JH
    J Electrocardiol; 1990 Jan; 23(1):77-83. PubMed ID: 2406361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the response to intravenous procainamide during electrophysiologic study in predicting the response to oral quinidine in patients with inducible sustained monomorphic ventricular tachycardia associated with coronary artery disease.
    Pires LA; Wagshal AB; Greene TO; Mittleman RS; Huang SK
    Am J Cardiol; 1993 Oct; 72(12):908-10. PubMed ID: 8105674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.